ClassID:

96111

C07F9/582 - CPC Classification

Classification description:

Recent Application in this class:
#1
20190019959
2019-01-17

Phosphine-based compound and organic electroluminescence device including the same

#2
20180305383
2018-10-25

Kinase inhibitors

#3
20180305382
2018-10-25

HYDROGENATION OF ESTERS WITH FE/TRIDENTATE LIGANDS COMPLEXES

#4
20180258043
2018-09-13

PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING

#5
20180166639
2018-06-14

CONDENSED CYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME

#6
20180064829
2018-03-08

FLUORESCENT BISPHOSPHONATE ANALOGS

#7
20180044361
2018-02-15

Prodrugs of pyridone amides useful as modulators of sodium channels

#8
20180036724
2018-02-08

Ligand components, associated reaction products, activated reaction products, hydrosilylation catalysts and hydrosilylation curable compositions including the ligand components, and associated methods for preparing same

#9
20180002357
2018-01-04

Process for the preparation of acylphosphanes

#10
20170360041
2017-12-21

N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2- trifluoroacetamide for control of agricultural/horticultural pests

#11
20170329195
2017-11-16

Organic compound, electrochromic compound, and electrochromic element, optical filter, lens unit, imaging device, and window component having same

#12
20170291917
2017-10-12

Kinase inhibitors

#13
20170152274
2017-06-01

Charged linkers and their uses for conjugation

#14
20170056426
2017-03-02

Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome

#15
20170015627
2017-01-19

PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING

#16
20160376295
2016-12-29

Prodrugs of pyridone amides useful as modulators of sodium channels

#17
20160331679
2016-11-17

Methods for the safe administration of imidazole or imidazolium compounds

#18
20160318958
2016-11-03

Urea derivatives useful as kinase inhibitors

#19
20160318956
2016-11-03

Hydrogenation of esters with Fe/tridentate ligands complexes

#20
20160205933
2016-07-21

N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide for control of agricultural/horticultural pests

#21
20160194342
2016-07-07

Phenicol antibacterials

#22
20160107151
2016-04-21

Ligand, metal complex containing ligand, and reaction using metal complex containing ligand

#23
20160037034
2016-02-04

Near-infrared-ray-absorbing composition, near-infrared-ray cut filter using same, manufacturing method therefor, camera module, and manufacturing method therefor

#24
20160009743
2016-01-14

Prodrugs of pyridone amides useful as modulators of sodium channels

#25
20150299231
2015-10-22

Process for the preparation of acylphosphanes

#26
20150274761
2015-10-01

Electrochromic compound, electrochromic composition, and display element

#27
20150266910
2015-09-24

Phenicol antibacterials

#28
20150191495
2015-07-09

Antidiabetic tricyclic compounds

#29
20150157564
2015-06-11

Methods for the safe administration of imidazole or imidazolium compounds

#30
20150119365
2015-04-30

Activators of glucokinase

#31
20150105427
2015-04-16

N-[1-((6-chloropyridin-3-yl) methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide for control of animal parasitic pests and agricultural/horticultural pests

#32
20150065466
2015-03-05

NOVEL DXR INHIBITORS FOR ANTIMICROBIAL THERAPY

#33
20150065415
2015-03-05

Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide

#34
20150025039
2015-01-22

Antiviral phosphonate analogs

#35
20140316533
2014-10-23

Endosseous implant

#36
20140193801
2014-07-10

Schiff-base conjugate of N, N-dibutyl-P-phenylenediamine with pyridoxal 5′-phosphate for improved homocysteine assays using pyridoxal 5′-phosphate-dependent enzymes

#37
20140135530
2014-05-15

Compound and organic device employing same

#38
20140051666
2014-02-20

Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide

#39
20130296276
2013-11-07

Heterocyclic ring compound having muscle cell or adipocyte differentiation regulating action

#40
20130281664
2013-10-24

Ruthenium complexes and their uses in processes for formation and/or hydrogenation of esters, amides and derivatives thereof

#41
20130237502
2013-09-12

Phenicol antibacterials

#42
20130203702
2013-08-08

Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof

#43
20130116214
2013-05-09

HETEROCYCLIC RING COMPOUND

#44
20120225847
2012-09-06

Squaric acid derivatives as inhibitors of the nicotinamide

#45
20120220551
2012-08-30

Phosphorus containing compounds as protein kinase inhibitors

#46
20120181514
2012-07-19

Compound and organic light-emitting diode, display and illuminating device using the compound

#47
20120140439
2012-06-07

Rare-earth complex and uses thereof

#48
20110294758
2011-12-01

Activators of glucokinase

#49
20110294664
2011-12-01

Use of derivatives of (1-cyanocyclopropyl)phenylphosphinic acid, esters thereof and/or salts thereof for enhancing tolerance in plants to abiotic stress

#50
20100297368
2010-11-25

Optically compensated acrylic pressure-sensitive adhesive composition, polarizing plate and liquid crystal display device containing the same

#51
20100280273
2010-11-04

Hydrogenation of esters with Ru/bidentate ligands complexes

#52
20100130754
2010-05-27

HYDROGENATION OF ESTERS WITH RU/BIDENTATE LIGANDS COMPLEXES

#53
20080071121
2008-03-20

Hydrogenation of esters with Ru/bidentate ligands complexes